Incidence of new-onset diabetes among sudanese renal transplant patients using different immunosuppressive regimens: A retrospective study
Background: New onset diabetes after renal transplant (NODAT) is a serious complication of therapy with immunosuppressive drugs. The aim of this study was to estimate the incidence of NODAT and its association with immunosuppressant regimens within 6 months of the administration. Methodology: A desc...
Saved in:
Main Authors: | Alaa Mohammedazeem Elzain, Safaa Badi, Bashir Alsiddig Yousef, Habab Khalid Elkheir |
---|---|
Format: | article |
Language: | EN |
Published: |
Wolters Kluwer Medknow Publications
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e4f8520dfd754aa7a43f227f58c87e0f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Post-Transplant Malignancies following Pancreas Transplantation: Incidence and Implications on Long-Term Outcome from a Single-Center Perspective
by: Felix J. Krendl, et al.
Published: (2021) -
Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response
by: Florian Terrec, et al.
Published: (2021) -
Immunogenetics of new onset diabetes after transplantation in Kuwait
by: Jahromi M, et al.
Published: (2019) -
Post-transplantation diabetes mellitus: an overview
by: Igor Alexandrovich Sklyanik, et al.
Published: (2015) -
Comparison of COVID-19 outcomes in organ transplant recipients (OTr) and non-transplant patients: a study protocol for rapid review
by: Alexis H. Lerner, et al.
Published: (2021)